Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Asahi Kasei Pharma America Corp.

Division of Asahi Kasei Corp.

Latest From Asahi Kasei Pharma America Corp.

Asahi Kasei aims for global market through Phase III trials with novel anticoagulant

The diversified Japanese materials group Asahi Kasei is planning to take its recombinant human thrombomodulin-alfa product ART-123 into the global arena through the start of an international Phase III trial for the treatment of severe sepsis and coagulopathy.

Cardiovascular Japan

Device/Diagnostics Quarterly Deal Statistics, Q1 2012

Medical device companies raised $1.1 billion, a 40% increase over Q4 2011’s $800 million. Two billion-dollar deals in the resuscitation market boosted device acquisition activity to $4.2 billion. Twenty diagnostics financings brought in a collective $302 million, soaring above the previous quarter’s $269 million. There were seven diagnostics M&A deals completed, totaling $589 million – down yet again.

Medical Device Deals

Deals Shaping The Medical Industry (12/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device

Japan’s AKP Takes Over Artisan To Progress ART-123

Japan's Asahi Kasei Pharma announced Nov. 22 that its acquisition of Massachusetts-based Artisan Pharma, a company it spun out in 2006.

See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Alias(es)
  • Artisan Pharma Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Asahi Kasei Corp.
  • Senior Management
  • Naoyuki Ono, Chmn. & CEO
    Inder Kaul, MD, CMO
    John Charest, Sr. Dir., Fin.
    Kazuhisa Tsuruta, SVP, CSO
  • Contact Info
  • Asahi Kasei Pharma America Corp.
    Phone: (781) 419-1919
    230 Third Ave.
    Waltham, MA 02451